Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Maternal exposure timing unspecified? 303 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 303 reports of Maternal exposure timing unspecified have been filed in association with INFLIXIMAB (Renflexis). This represents 0.2% of all adverse event reports for INFLIXIMAB.

303
Reports of Maternal exposure timing unspecified with INFLIXIMAB
0.2%
of all INFLIXIMAB reports
184
Deaths
213
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From INFLIXIMAB?

Of the 303 reports, 184 (60.7%) resulted in death, 213 (70.3%) required hospitalization, and 200 (66.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 303 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) LEFLUNOMIDE (302) SECUKINUMAB (301) OXYCODONE (300)

Which INFLIXIMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified INFLIXIMAB Demographics